Raymond Schiffelers is a professor from the Dept. of Clinical Chemistry and Hematology, UMC Utrecht (Netherlands). He obtained his PhD from Erasmus University Medical Center Rotterdam (Netherlands). His thesis was focused on liposomal targeting of antimicrobial agents. From 2000-2011, he worked at the Dept. of Pharmaceutics of Utrecht University developing polymers, micelles and liposomes loaded with small molecular weight drugs as well as biologicals, targeting a variety of diseases. Within this period, he worked for Intradigm Co. (USA) (2002-2003) on formulations for in vivo targeting of siRNA. In 2007, he obtained a Vidi grant from NWO to start his own research line. In 2009 he received the Galenus Research Award for his work in drug delivery and in 2010 he was awarded an ERC Starting Grant (consolidator phase) to investigate extracellular vesicles for drug delivery. In 2011, he moved to University Medical Center Utrecht where he complements his research lines on drug targeting with investigations on nanoparticles in diagnostic applications. Raymond Schiffelers is also the cordinator of the H2020 project B-SMART on targeting RNA to the brain and national HighTech Systems Materials project (Targeting of multiple myeloma)/KWF-STW Technology for Oncology (Targeting glioblastoma)/NWO-CW Launchpad for Innovative Future Technologies (Innovative diagnostics for glioblastoma).